C2C Advanced Systems IPO gets 116x subscription despite bid withdrawal option after Sebi scrutiny

C2C Advanced Systems IPO gets 116x subscription despite bid withdrawal option after Sebi scrutiny

There is no dearth of demand for C2C Advanced Systems IPO despite being in troubled waters following a Sebi directive that delayed its listing of shares. The issue, which closed for subscription today, was subscribed by a whopping 116 times. The IPO received bids for 36.56 crore shares as against 31 lakh shares on offer. … Read more

Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year. Revenue rose 7% YoY to Rs 3,434 crore in Q2FY25. EBITDA grew 30.2% YoY to Rs 602 crore, … Read more

Apollo Hospitals shares surge 6% on 63% YoY jump in Q2 profit

Apollo Hospitals shares surge 6% on 63% YoY jump in Q2 profit

Shares of Apollo Hospitals surged 6% to their all-time high of Rs 7,396.30 on the BSE after the company reported a 63% year-on-year (YoY) jump in net profit to Rs 379 crore in Q2FY25, led by its hospital business.The company reported a net profit of Rs 233 crore in the corresponding quarter of the previous … Read more

Sudarshan Chemical Industries acquires Germany-based world’s second biggest pigment company Heubach Group

Sudarshan Chemical Industries acquires Germany-based world’s second biggest pigment company Heubach Group

Shares of Sudarshan Chemical Industries hit a 20% upper circuit at Rs 1,207.50 on Friday following the announcement of its acquisition of Germany-based world’s second biggest pigment company Heubach Group through an asset and share deal. Heubach GmbH, filed for bankruptcy in Germany in April. In a stock exchange disclosure, Sudarshan Chemical stated that it … Read more

Metropolis Q1 results: Net profit rises 31% to Rs 38 crore

Metropolis Q1 results:  Net profit rises 31% to Rs 38 crore

Metropolis Healthcare on Saturday reported a 31.3% year-on-year (YoY) rise in net profit to Rs 38.1 crore in Q1FY25 let my volume increase and better patient realisations. The diagnostic chain reported Rs 29 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 13.1% YoY to Rs 313.4 crore. … Read more

DLF Q1 Results: Consolidated PAT jumps 23% YoY to Rs 646 crore, revenue falls 4%

DLF Q1 Results: Consolidated PAT jumps 23% YoY to Rs 646 crore, revenue falls 4%

Realty major DLF Ltd on Thursday reported 23% growth in its consolidated net profit at Rs 646 crore for the first quarter. It was Rs 527 crore in the last year quarter. Revenue from operations in the reporting quarter fell 4% year-on-year to Rs 1,362 crore as against Rs 1423 crore in the same quarter … Read more

Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?

Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?

Shares of Apollo Hospitals rallied 3.4% in Friday’s early trade to the day’s high of Rs 5,955 after the company reported a 77% year-on-year (YoY) jump in its net profit. The company’s revenue from operations in the January-March 2024 period increased 15% YoY to Rs 4,944 crore and the board of directors have also recommended … Read more

Campus Activewear shares rally 13% after Q4 results. Should you buy, sell or hold?

Campus Activewear shares rally 13% after Q4 results. Should you buy, sell or hold?

Shares of Campus Activewear on Wednesday rallied 13% after the company reported a 42.6% YoY increase in its PAT for the fourth quarter of the financial year 2024. The company also posted a 4.6% YoY increase in revenue at Rs 363.9 crore while the EBITDA rose by 16% at Rs 66.4 crore vs Rs 57.1 … Read more

Max Healthcare net profit growth down due to higher taxes: Abhay Soi

Max Healthcare net profit growth down due to higher taxes: Abhay Soi

Abhay Soi, MD & CEO, Max Healthcare, says in the previous year, EBITDA to free cash flow translation used to be 78%, it has come down to 70%. It is due to the higher amount of taxes that Max Healthcare is paying. Soi further says that any hospital chain which has capacity constraints going forward … Read more

Indegene looking forward to enhancing EBITDA & PAT margins: Management

Indegene looking forward to enhancing EBITDA & PAT margins: Management

Manish Gupta, Chairman & CEO and Suhas Prabhu, CFO, Indegene, in conversation with ET Now. says: “The margin, especially at the EBITDA level, has consistently grown from 18.8% to 21.9%. We will look at sustaining and growing the margins as we go forward. Another aspect, given the proceeds from the IPO would be to go … Read more